🇺🇸 FDA
Pipeline program

NORADRENALINA TARTRATO MONICO 2 mg/ml Concentrato per soluzione per infusione

IRFMN-9063

Phase 3 small_molecule active

Quick answer

NORADRENALINA TARTRATO MONICO 2 mg/ml Concentrato per soluzione per infusione for criticall illness is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
criticall illness
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials